News

Nvidia (NASDAQ: NVDA) stock rose 0.3% and Hewlett Packard Enterprise (NYSE: HPE) rose 1.2% after the tech companies said they ...
Merck (MRK) stock is in focus as its Enflonsia RSV shot is cleared for infants in the U.S. in a market led by Sanofi (SNY) ...
On the currency front, sterling weakened as Bank of England easing bets rose following the release of the latest UK labor ...
With precious little to report out of Sino-U.S. trade talks in London, investors are ready to pounce on almost any sign a ...
From June 22-25, 160 leading minds will explore cutting-edge innovations and pressing issues shaping the future of health, medicine, and science. Spe ...
Tesla trades lower ahead of the possible launch of its robo-taxi service this week in Austin, Texas, while Apple’s annual ...
The Justice Department says Gugnin maintained ties to Russian intelligence, as well as officials in both Iran and Russia.
Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
The latest poll showed less than 30% of CEOs expected some sort of recession or slowdown over the next six months.